Skip to content

Surgical treatment of Parkinson's disease with deep brain stimulation

Application of diffusion tensor imaging in deep brain stimulation of subthalamic nucleus in patients with primary Parkinson's disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021800
Enrollment
Unknown
Registered
2019-03-10
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

experimental group :Diffusion tensor imaging MRI3D-swan guided deep brain stimulation
control group:Conventional thin-layer MRI-T2 guided deep brain electrode stimulation

Sponsors

Neurosurgery Department, Yijishan Hospital, Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Primary Parkinson's disease (2. 5-4 level); 2. Patients who have responded well to levodopa and have maintained serious symptoms that are beyond the control of drug adjustment; 3. Patients with motor fluctuations and / or severe dyskinesia; 4. Patients with normal cognitive ability (without dementia); 5. Patients should have reasonable surgical expectations and good family support; 6. patients who can be programmed by a nerve stimulator.

Exclusion criteria

Exclusion criteria: 1. Parkinson's disease: (patients who do not respond to or do not respond to levodopa; patients with secondary Parkinson's disease or Parkinson's syndrome; patients with poor "open" state); 2. Mattis dementia scale for patients with significant cognitive impairment; 3. A person who cannot be treated for depression or other mental illness; 4. A patient who is unwilling or unable to cooperate with the operation; 5. Patients who are unwilling or unable to cooperate with postoperative follow-up; 6. Patients in poor overall health; 7. Patients at high risk of neurosurgery (brain injury, severe brain atrophy, coagulation, uncontrollable hypertension); 8. Patients who need diathermy; 9. Contraindication: patients with diabetes, immunosuppressants, implanted pacemakers, patients who need to perform MRI over and over again.

Design outcomes

Primary

MeasureTime frame
a-synuclein;

Countries

China

Contacts

Public ContactYi Dai

Neurosurgery Department, Yijishan Hospital, South Anhui Medical College

yjsyy0775@163.com+86 13966006108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026